Who is sponsoring NCT02728076?

NCT02728076 is sponsored by Medical College of Wisconsin.

What condition does NCT02728076 study?

NCT02728076 studies Breast Cancer.

What drugs are being tested in NCT02728076?

Interventions: Phase II - Preoperative Radiation followed by Lumpectomy..

What is the status of NCT02728076?

NCT02728076 is currently ACTIVE_NOT_RECRUITING.

Last reviewed 2026-02-01 · How we verify

Phase II Study of MRI-Based Preoperative Accelerated Partial Breast Irradiation

NCT02728076 NA ACTIVE_NOT_RECRUITING Results posted

This study examines the feasibility to deliver accelerated partial breast irradiation (APBI) before a lumpectomy is performed. By administering the APBI before the lumpectomy, a smaller volume of breast tissue may be exposed to radiation. The APBI method used in this study is 3D (three dimensional) conformal external beam irradiation. 3D-conformal external beam irradiation uses an X-ray beam to deliver the radiation dose. Traditionally, CT imaging is used to plan treatment. In this study, an MRI will be used. Approximately five to eight weeks after completion of the APBI, the cancer will be surgically removed.

Details

Lead sponsor	Medical College of Wisconsin
Phase	NA
Status	ACTIVE_NOT_RECRUITING
Enrolment	39
Start date	2016-07-29
Completion	2026-07

Conditions

Breast Cancer

Interventions

Phase II - Preoperative Radiation followed by Lumpectomy.

Primary outcomes

Postoperative Complications Following — 3 Months
The number of subjects with one or more postoperative complications following preoperative accelerated partial breast irradiation within three months of surgery.

Countries

United States